Trexquant Investment’s Wave Life Sciences WVE Stock Holding History

Trexquant Investment’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.9M	Buy	1,089,642 +698,531	+179%	+$9.1M	0.06%	463
2025 Q4	$6.65M	Buy	+391,111	New	+$3.97M	0.06%	461
2025 Q2	–	Sell	-223,412	Closed	-$1.81M	–	1937
2025 Q1	$1.81M	Sell	223,412 -215,940	-49%	-$2.36M	0.02%	903
2024 Q4	$5.43M	Buy	439,352 +150,538	+52%	+$2.01M	0.06%	497
2024 Q3	$2.37M	Buy	288,814 +7,754	+3%	+$46.4K	0.03%	748
2024 Q2	$1.4M	Buy	281,060 +168,428	+150%	+$961K	0.02%	881
2024 Q1	$695K	Buy	112,632 +80,513	+251%	+$403K	0.01%	1046
2023 Q4	$162K	Buy	+32,119	New	+$172K	﹤0.01%	1349
2021 Q1	–	Sell	-30,070	Closed	-$237K	–	1519
2020 Q4	$237K	Buy	+30,070	New	+$252K	0.03%	816
2019 Q2	–	Sell	-5,145	Closed	-$200K	–	1167
2019 Q1	$200K	Buy	+5,145	New	+$209K	0.01%	871

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Trexquant Investment's WVE Position: Q1 2026 in Review

Trexquant Investment increased its Wave Life Sciences (WVE) stake by 179% in Q1 2026, buying an estimated $9.1M and bringing the position to 1,089,642 shares worth $7.9M. The position accounts for 0.06% of the portfolio, ranked #463.

Trexquant Investment first reported a position in WVE in Q1 2019 and has held it in 10 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Trexquant Investment held 1,089,642 shares of Wave Life Sciences worth $7.9M as of Q1 2026.
Trexquant Investment bought 698,531 Wave Life Sciences shares in Q1 2026, an estimated $9.1M.
Wave Life Sciences made up 0.06% of Trexquant Investment's portfolio in Q1 2026, its #463 holding.
Trexquant Investment first reported a position in Wave Life Sciences in Q1 2019 and has held it in 10 quarters since.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.